Extended Data Fig. 2: Molecular tumor board activity and treatment outcomes in the intention-to-treat (ITT) population.
From: Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial
MTB outcomes. Molecular tumor board activity and treatment allocation in the intention-to-treat (ITT) population.
